Back to results
US 2026/0217653 A1Published application
Crystalline compound of an lpar1 antagonist
AssigneeContineum Therapeutics, Inc.
InventorsJeffrey Roger ROPPE, Austin Chih-Yu CHEN, Yifeng XIONG, Thomas SCHRADER, Lino VALDEZ
Life of this patent
Estimating the term…
Abstract
Described herein, inter alia, a crystalline compound of an LPAR1 antagonist, pharmaceutical compositions including the crystalline compound, and methods of treatment using the same.
Claims22
A crystalline compound having the formula:
- wherein the crystalline compound has characteristic X-ray powder diffraction peaks at about 5.2° 2θ, about 10.4° 2θ, and about 15.6° 2θ.
Dependencies are inferred from the claim text.